Indole-4-carboxaldehyde Isolated from Seaweed, Sargassum thunbergii, Attenuates Methylglyoxal-Induced Hepatic Inflammation
SCIE
SCOPUS
Cited 12 time in
WEB OF SCIENCE
Cited 12 time in
Scopus
-
Title
- Indole-4-carboxaldehyde Isolated from Seaweed, Sargassum thunbergii, Attenuates Methylglyoxal-Induced Hepatic Inflammation
-
Author(s)
- Cha, Seon-Heui; Hwang, Yongha; Heo, Soo-Jin; Jun, Hee-Sook
- KIOST Author(s)
- Heo, Soo Jin(허수진)
-
Alternative Author(s)
- 허수진
-
Publication Year
- 2019-09
-
Abstract
- Glucose degradation is aberrantly increased in hyperglycemia, which causes various harmful effects on the liver. Glyoxalase-1 (Glo-1) is a ubiquitous cellular enzyme that participates in the detoxification of methylglyoxal (MGO), a cytotoxic byproduct of glycolysis that induces protein modification (advanced glycation end-products, AGEs) and inflammation. Here, we investigated the anti-inflammatory effect of indole-4-carboxaldehyde (ST-I4C), which was isolated from the edible seaweed Sargassum thunbergii, on MGO-induced inflammation in HepG2 cells, a human hepatocyte cell line. ST-I4C attenuated the MGO-induced expression of inflammatory-related genes, such as tumor necrosis factor (TNF)-alpha and IFN-gamma by activating nuclear factor-kappa B (NF-kappa B) without toxicity in HepG2 cells. In addition, ST-I4C reduced the MGO-induced AGE formation and the expression of the receptor for AGE (RAGE). Interestingly, both the mRNA and protein expression levels of Glo-1 increased following ST-I4C treatment, and the decrease in Glo-1 mRNA expression caused by MGO exposure was rescued by ST-I4C pretreatment. These results suggest that ST-I4C shows anti-inflammatory activity against MGO-induced inflammation in human hepatocytes by preventing an increase in the pro-inflammatory gene expression and AGE formation. Therefore, it represents a potential therapeutic agent for the prevention of hepatic steatosis.
-
ISSN
- 1660-3397
-
URI
- https://sciwatch.kiost.ac.kr/handle/2020.kiost/38844
-
DOI
- 10.3390/md17090486
-
Bibliographic Citation
- MARINE DRUGS, v.17, no.9, 2019
-
Publisher
- MDPI
-
Subject
- FATTY LIVER-DISEASE; END-PRODUCTS AGES; GLYOXALASE-I; ENDOTHELIAL-CELLS; SERUM-LEVELS; RECEPTOR; PHOSPHORYLATION; DERIVATIVES; FRUCTOSE; STRESS
-
Keywords
- hepatic steatosis; metabolic disease; AGEs; seaweed; Sargassum thunbergii
-
Type
- Article
-
Language
- English
-
Document Type
- Article
- Files in This Item:
-
There are no files associated with this item.
Items in ScienceWatch@KIOST are protected by copyright, with all rights reserved, unless otherwise indicated.